Josef Jampilek completed his Ph.D. degree in Medicinal Chemistry at the Faculty of Pharmacy of the Charles University (Czechia) in 2004. In 2004-2011, he worked in expert and managerial posts in the R&D Division of the pharmaceutical company Zentiva (Czechia). Prof. Jampilek deepened his professional knowledge at the Medicinal Chemistry Institute of the Heidelberg University (Germany) and at multiple specialized courses. In 2017, he was designated as a Full Professor of Medicinal Chemistry. He works at the Faculty of Natural Sciences of the Comenius University in Bratislava (Slovakia) and the Faculty of Science of the Palacky University in Olomouc (Czechia). In addition, he is a visiting professor at the University of Silesia in Katowice (Poland) and an invited professor/expert at various higher educational institutions. He is an author/co-author of more than 35 patents/patent applications, more than 290 peer-reviewed scientific publications, 7 textbooks, more than 50 chapters in monographs, and many invited lectures at international conferences and workshops. He also received several awards for his scientific results, e.g., from Aventis, Sanofi and FDA. Since 2020, he has been listed in the "World's Top 2% Scientists" ranking announced by Stanford University & Elsevier. The research interests of Prof. Jampilek include drug design, medicinal chemistry, chemical biology, as well as nanosystems for drug and agrochemical delivery.